AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $24,432,400 | +131938.5% | 340,000 | +13.3% | 1.37% | +12.3% |
Q1 2023 | $18,504 | -26.2% | 300,000 | -7.7% | 1.22% | -27.3% |
Q4 2022 | $25,067 | -99.7% | 325,000 | +58.5% | 1.68% | +182.3% |
Q2 2022 | $7,852,000 | -30.7% | 205,000 | +2.5% | 0.59% | +135.7% |
Q1 2021 | $11,324,000 | -30.5% | 200,000 | 0.0% | 0.25% | -35.1% |
Q4 2020 | $16,294,000 | -8.5% | 200,000 | -20.0% | 0.39% | -43.4% |
Q3 2020 | $17,813,000 | -38.1% | 250,000 | -28.6% | 0.68% | -37.7% |
Q2 2020 | $28,798,000 | -2.1% | 350,000 | -30.0% | 1.10% | -19.6% |
Q1 2020 | $29,415,000 | -52.6% | 500,000 | -16.7% | 1.37% | -44.8% |
Q4 2019 | $62,016,000 | – | 600,000 | – | 2.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |